|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/436 | (2006.01) |
| A61K 9/0019 | (2013.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 47/34 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 31/436 | (2013.01) | ||
| A61K 47/20 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 47/22 | (2006.01) | ||
| A61K 47/24 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/34 | (2017.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 3565553 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17890478.5 |
| Date of filing the European patent application | 2017-12-29 | |
| (97) | Date of publication of the European application | 2019-11-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2017/047408 |
| Date | 2017-12-29 |
| (87) | Number | WO 2018/128173 |
| Date | 2018-07-12 |
| (30) | Number | Date | Country code |
| 201762443599 P | 2017-01-06 | US |
| (72) |
KUNDU, Aishwarya , US
ESCUDERO, Cecile , US
MUDUMBA, Sreenivasu , US
|
| (73) |
Santen Pharmaceutical Co., Ltd. ,
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku
Osaka-shi
Osaka 533-8651,
JP
|
| (54) | INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER |
| INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER |